GlucoStem
Escape's universal embryonic stem cell, PluraStem, allows for the creation of an off-the-shelf β
cell that can be transplanted into patients of any HLA type, without the need for lifelong immunosuppression.
Escape's research stage universal β cell product, GlucoStem, holds great promise to liberate type I diabetes
from insulin dependence.